ArticleAvicenna journal of phytomedicine
The modulatory role of 6-gingerol-rich portion of ginger on brain oxidative stress, inflammation and neurotransmission in chronic unpredicted mild stress-induced depressed male Wistar rats.
Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study was designed to investigate the effect of 6-gingerol-rich extract of ginger (6-GIRPOG) on oxidative stress, inflammation and neurotransmission in chronic unpredicted mild stress (CUMS)-induced depressed male Wistar rats. Materials and Methods: Twenty-five (25) male Wistar rats in total were divided into five groups at random (n = 5 in each group). The control group received 0.5 ml of normal saline, CUMS rats were only exposed to CUMS daily, CUMS + fluoxetine rats were exposed to CUMS and orally received 10 mg/kg per body weight of fluoxetine daily, CUMS + 6-GIRPOG (100) and CUMS + 6-GIRPOG (200) rats were exposed to CUMS and orally received 100 and 200 mg/kg body weight of 6-GIRPOG respectively (daily). Exposure to CUMS and treatment were carried out for a period of 21 days, after which light and dark box test, sucrose splash test, and forced swim test were conducted to assess the behavioral functions. The rats were then euthanized and their brain samples were collected for biochemical analysis. Results: The exposure to CUMS caused behavioral alterations as well as a significant (p<0.05) decrease in the levels of brain-derived neurotrophic factor (BDNF), glutamate, reduced glutathione (GSH), and activities of superoxide dismutase (SOD). Furthermore, the exposure to CUMS caused a statistically significant rise (p<0.05) in the brain norepinephrine, cortisol, nuclear factor kappa-B (NFK-B), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6. However, the administration of both 100 and 200 mg/kg of 6-GIRPOG effectively reversed these behavioral and biochemical changes. Conclusion: Consequently, the study reveals the role of 6-GIRPOG in ameliorating CUMS-induced depression and brain damage via antioxidative, anti-inflammatory, and neurotransmission modulatory mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.